Cefdirnir en es it fr

Cefdirnir Brand names, Cefdirnir Analogs

Cefdirnir Brand Names Mixture

  • No information avaliable

Cefdirnir Chemical_Formula


Cefdirnir RX_link


Cefdirnir fda sheet

Cefdirnir FDA

Cefdirnir msds (material safety sheet)

Cefdirnir MSDS

Cefdirnir Synthesis Reference

No information avaliable

Cefdirnir Molecular Weight

395.416 g/mol

Cefdirnir Melting Point

No information avaliable

Cefdirnir H2O Solubility

No information avaliable

Cefdirnir State


Cefdirnir LogP


Cefdirnir Dosage Forms

Capsules for oral administration (300mg); Oral suspension (125mg per 5mL solution)

Cefdirnir Indication

For the treatment of the respiratory, skin, soft tissue, and ENT infections caused by H. influenzae (including b-lactamase producing strains), H. parainfluenzae (including b-lactamase producing strains), S. pneumoniae (penicillin-susceptible strains), S. pyogenes, S. aureus (including b-lactamase producing strains), and M. catarrhalis.

Cefdirnir Pharmacology

Cefdinir is a third generation cephalosporin with a broad spectrum of activity against enteric gram-negative rods. Cefdinir is stable in the presence of some, but not all, b-lactamase enzymes. As a result, many organisms resistant to penicillins and some cephalosporins are susceptible to cefdinir. Cephalosporins work the same way as penicillins: they interfere with the peptidoglycan synthesis of the bacterial wall by inhibiting the final transpeptidation needed for the cross-links. This effect is bactericidal.

Cefdirnir Absorption

Maximal plasma cefdinir concentrations occur 2 to 4 hours postdose following capsule or suspension administration. Estimated bioavailability of cefdinir capsules is 21% following administration of a 300 mg capsule dose, and 16% following administration of a 600 mg capsule dose. Estimated absolute bioavailability of cefdinir suspension is 25%. Absorption is reduced by approximately 15% when administered with a high fat meal.

Cefdirnir side effects and Toxicity

Information on cefdinir overdosage in humans is not available. In acute rodent toxicity studies, a single oral 5600-mg/kg dose produced no adverse effects. Toxic signs and symptoms following overdosage with other b-lactam antibiotics have included nausea, vomiting, epigastric distress, diarrhea, and convulsions.

Cefdirnir Patient Information

Cefdirnir Organisms Affected

Enteric gram-negative rods